Rod Szarka has been appointed business development manager, QSV Biologics Ltd. He will be responsible for new business in California. Mr. Szarka has more than16 years of experience in drug research and development and four years of business development experience with pharmaceutical clinical trials. Prior to joining the company he was manager of business development at Global IQ. He spent several years with Cytovax Biotechnologies as laboratory research manager, where he was responsible for supervising, instructing and guiding research technicians in the microbiology, immunology and animal research unit. Mr. Szarka also spent time at ChemBioMed Ltd. and the Alberta Research Council.
   
Dr. Graeme Macaloney, QSV’s president and chief executive officer, said, “Rod brings a strong ability to research potential companies and cultivate client relationships in the highly active California market for QSV. He couples this with a broad knowledge of protein, monoclonal antibody and vaccine drug development. Rod is a welcomed addition to the QSV Biologics team as he brings a professionalism and customer service ethic consistent with QSVs culture and reputation.”